Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Biosimilars
Revenue, means the sales value of Biosimilars
This report studies sales (consumption) of Biosimilars in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Bayer
Vencorex
BASF
Asahi Kasei
NPU
Wanhua
Amgen
Celltrion
Roche Diagnostics?
Merck KGaA
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Biosimilars in these regions, from 2011 to 2021 (forecast), like
USA
China
Europe
Japan
India
Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into
Application 1
Application 2
Application 3
Global Biosimilars Sales Market Report 2016
1 Biosimilars Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Biosimilars
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Biosimilars Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Biosimilars (2011-2021)
1.5.1 Global Biosimilars Sales and Growth Rate (2011-2021)
1.5.2 Global Biosimilars Revenue and Growth Rate (2011-2021)
2 Global Biosimilars Competition by Manufacturers, Type and Application
2.1 Global Biosimilars Market Competition by Manufacturers
2.1.1 Global Biosimilars Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Biosimilars Revenue and Share by Manufacturers (2011-2016)
2.2 Global Biosimilars (Volume and Value) by Type
2.2.1 Global Biosimilars Sales and Market Share by Type (2011-2016)
2.2.2 Global Biosimilars Revenue and Market Share by Type (2011-2016)
2.3 Global Biosimilars (Volume and Value) by Regions
2.3.1 Global Biosimilars Sales and Market Share by Regions (2011-2016)
2.3.2 Global Biosimilars Revenue and Market Share by Regions (2011-2016)
2.4 Global Biosimilars (Volume) by Application
3 USA Biosimilars (Volume, Value and Sales Price)
3.1 USA Biosimilars Sales and Value (2011-2016)
3.1.1 USA Biosimilars Sales and Growth Rate (2011-2016)
3.1.2 USA Biosimilars Revenue and Growth Rate (2011-2016)
3.1.3 USA Biosimilars Sales Price Trend (2011-2016)
3.2 USA Biosimilars Sales and Market Share by Manufacturers
3.3 USA Biosimilars Sales and Market Share by Type
3.4 USA Biosimilars Sales and Market Share by Application
4 China Biosimilars (Volume, Value and Sales Price)
4.1 China Biosimilars Sales and Value (2011-2016)
4.1.1 China Biosimilars Sales and Growth Rate (2011-2016)
4.1.2 China Biosimilars Revenue and Growth Rate (2011-2016)
4.1.3 China Biosimilars Sales Price Trend (2011-2016)
4.2 China Biosimilars Sales and Market Share by Manufacturers
4.3 China Biosimilars Sales and Market Share by Type
4.4 China Biosimilars Sales and Market Share by Application
5 Europe Biosimilars (Volume, Value and Sales Price)
5.1 Europe Biosimilars Sales and Value (2011-2016)
5.1.1 Europe Biosimilars Sales and Growth Rate (2011-2016)
5.1.2 Europe Biosimilars Revenue and Growth Rate (2011-2016)
5.1.3 Europe Biosimilars Sales Price Trend (2011-2016)
5.2 Europe Biosimilars Sales and Market Share by Manufacturers
5.3 Europe Biosimilars Sales and Market Share by Type
5.4 Europe Biosimilars Sales and Market Share by Application
6 Japan Biosimilars (Volume, Value and Sales Price)
6.1 Japan Biosimilars Sales and Value (2011-2016)
6.1.1 Japan Biosimilars Sales and Growth Rate (2011-2016)
6.1.2 Japan Biosimilars Revenue and Growth Rate (2011-2016)
6.1.3 Japan Biosimilars Sales Price Trend (2011-2016)
6.2 Japan Biosimilars Sales and Market Share by Manufacturers
6.3 Japan Biosimilars Sales and Market Share by Type
6.4 Japan Biosimilars Sales and Market Share by Application
7 India Biosimilars (Volume, Value and Sales Price)
7.1 India Biosimilars Sales and Value (2011-2016)
7.1.1 India Biosimilars Sales and Growth Rate (2011-2016)
7.1.2 India Biosimilars Revenue and Growth Rate (2011-2016)
7.1.3 India Biosimilars Sales Price Trend (2011-2016)
7.2 India Biosimilars Sales and Market Share by Manufacturers
7.3 India Biosimilars Sales and Market Share by Type
7.4 India Biosimilars Sales and Market Share by Application
8 Southeast Asia Biosimilars (Volume, Value and Sales Price)
8.1 Southeast Asia Biosimilars Sales and Value (2011-2016)
8.1.1 Southeast Asia Biosimilars Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Biosimilars Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Biosimilars Sales Price Trend (2011-2016)
8.2 Southeast Asia Biosimilars Sales and Market Share by Manufacturers
8.3 Southeast Asia Biosimilars Sales and Market Share by Type
8.4 Southeast Asia Biosimilars Sales and Market Share by Application
9 Global Biosimilars Manufacturers Analysis
9.1 Bayer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Biosimilars Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Bayer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Vencorex
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 123 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Vencorex Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 BASF
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 144 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 BASF Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Asahi Kasei
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Oct Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Asahi Kasei Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 NPU
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 NPU Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Wanhua
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Wanhua Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Amgen
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharmaceuticals Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Celltrion
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Roche Diagnostics?
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 Roche Diagnostics? Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Merck KGaA
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Merck KGaA Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
10 Biosimilars Maufacturing Cost Analysis
10.1 Biosimilars Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Biosimilars
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Biosimilars Market Forecast (2016-2021)
14.1 Global Biosimilars Sales, Revenue Forecast (2016-2021)
14.2 Global Biosimilars Sales Forecast by Regions (2016-2021)
14.3 Global Biosimilars Sales Forecast by Type (2016-2021)
14.4 Global Biosimilars Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Biosimilars
Table Classification of Biosimilars
Figure Global Sales Market Share of Biosimilars by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Biosimilars
Figure Global Sales Market Share of Biosimilars by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Biosimilars Revenue and Growth Rate (2011-2021)
Figure China Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Biosimilars Revenue and Growth Rate (2011-2021)
Figure Japan Biosimilars Revenue and Growth Rate (2011-2021)
Figure India Biosimilars Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Biosimilars Revenue and Growth Rate (2011-2021)
Figure Global Biosimilars Sales and Growth Rate (2011-2021)
Figure Global Biosimilars Revenue and Growth Rate (2011-2021)
Table Global Biosimilars Sales of Key Manufacturers (2011-2016)
Table Global Biosimilars Sales Share by Manufacturers (2011-2016)
Figure 2015 Biosimilars Sales Share by Manufacturers
Figure 2016 Biosimilars Sales Share by Manufacturers
Table Global Biosimilars Revenue by Manufacturers (2011-2016)
Table Global Biosimilars Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Biosimilars Revenue Share by Manufacturers
Table 2016 Global Biosimilars Revenue Share by Manufacturers
Table Global Biosimilars Sales and Market Share by Type (2011-2016)
Table Global Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Biosimilars by Type (2011-2016)
Figure Global Biosimilars Sales Growth Rate by Type (2011-2016)
Table Global Biosimilars Revenue and Market Share by Type (2011-2016)
Table Global Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilars by Type (2011-2016)
Figure Global Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Global Biosimilars Sales and Market Share by Regions (2011-2016)
Table Global Biosimilars Sales Share by Regions (2011-2016)
Figure Sales Market Share of Biosimilars by Regions (2011-2016)
Figure Global Biosimilars Sales Growth Rate by Regions (2011-2016)
Table Global Biosimilars Revenue and Market Share by Regions (2011-2016)
Table Global Biosimilars Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Biosimilars by Regions (2011-2016)
Figure Global Biosimilars Revenue Growth Rate by Regions (2011-2016)
Table Global Biosimilars Sales and Market Share by Application (2011-2016)
Table Global Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Biosimilars by Application (2011-2016)
Figure Global Biosimilars Sales Growth Rate by Application (2011-2016)
Figure USA Biosimilars Sales and Growth Rate (2011-2016)
Figure USA Biosimilars Revenue and Growth Rate (2011-2016)
Figure USA Biosimilars Sales Price Trend (2011-2016)
Table USA Biosimilars Sales by Manufacturers (2011-2016)
Table USA Biosimilars Market Share by Manufacturers (2011-2016)
Table USA Biosimilars Sales by Type (2011-2016)
Table USA Biosimilars Market Share by Type (2011-2016)
Table USA Biosimilars Sales by Application (2011-2016)
Table USA Biosimilars Market Share by Application (2011-2016)
Figure China Biosimilars Sales and Growth Rate (2011-2016)
Figure China Biosimilars Revenue and Growth Rate (2011-2016)
Figure China Biosimilars Sales Price Trend (2011-2016)
Table China Biosimilars Sales by Manufacturers (2011-2016)
Table China Biosimilars Market Share by Manufacturers (2011-2016)
Table China Biosimilars Sales by Type (2011-2016)
Table China Biosimilars Market Share by Type (2011-2016)
Table China Biosimilars Sales by Application (2011-2016)
Table China Biosimilars Market Share by Application (2011-2016)
Figure Europe Biosimilars Sales and Growth Rate (2011-2016)
Figure Europe Biosimilars Revenue and Growth Rate (2011-2016)
Figure Europe Biosimilars Sales Price Trend (2011-2016)
Table Europe Biosimilars Sales by Manufacturers (2011-2016)
Table Europe Biosimilars Market Share by Manufacturers (2011-2016)
Table Europe Biosimilars Sales by Type (2011-2016)
Table Europe Biosimilars Market Share by Type (2011-2016)
Table Europe Biosimilars Sales by Application (2011-2016)
Table Europe Biosimilars Market Share by Application (2011-2016)
Figure Japan Biosimilars Sales and Growth Rate (2011-2016)
Figure Japan Biosimilars Revenue and Growth Rate (2011-2016)
Figure Japan Biosimilars Sales Price Trend (2011-2016)
Table Japan Biosimilars Sales by Manufacturers (2011-2016)
Table Japan Biosimilars Market Share by Manufacturers (2011-2016)
Table Japan Biosimilars Sales by Type (2011-2016)
Table Japan Biosimilars Market Share by Type (2011-2016)
Table Japan Biosimilars Sales by Application (2011-2016)
Table Japan Biosimilars Market Share by Application (2011-2016)
Figure India Biosimilars Sales and Growth Rate (2011-2016)
Figure India Biosimilars Revenue and Growth Rate (2011-2016)
Figure India Biosimilars Sales Price Trend (2011-2016)
Table India Biosimilars Sales by Manufacturers (2011-2016)
Table India Biosimilars Market Share by Manufacturers (2011-2016)
Table India Biosimilars Sales by Type (2011-2016)
Table India Biosimilars Market Share by Type (2011-2016)
Table India Biosimilars Sales by Application (2011-2016)
Table India Biosimilars Market Share by Application (2011-2016)
Figure Southeast Asia Biosimilars Sales and Growth Rate (2011-2016)
Figure Southeast Asia Biosimilars Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Biosimilars Sales Price Trend (2011-2016)
Table Southeast Asia Biosimilars Sales by Manufacturers (2011-2016)
Table Southeast Asia Biosimilars Market Share by Manufacturers (2011-2016)
Table Southeast Asia Biosimilars Sales by Type (2011-2016)
Table Southeast Asia Biosimilars Market Share by Type (2011-2016)
Table Southeast Asia Biosimilars Sales by Application (2011-2016)
Table Southeast Asia Biosimilars Market Share by Application (2011-2016)
Table Bayer Basic Information List
Table Bayer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Biosimilars Global Market Share (2011-2016)
Table Vencorex Basic Information List
Table Vencorex Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Vencorex Biosimilars Global Market Share (2011-2016)
Table BASF Basic Information List
Table BASF Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BASF Biosimilars Global Market Share (2011-2016)
Table Asahi Kasei Basic Information List
Table Asahi Kasei Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Asahi Kasei Biosimilars Global Market Share (2011-2016)
Table NPU Basic Information List
Table NPU Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure NPU Biosimilars Global Market Share (2011-2016)
Table Wanhua Basic Information List
Table Wanhua Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Wanhua Biosimilars Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Biosimilars Global Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Biosimilars Global Market Share (2011-2016)
Table Roche Diagnostics? Basic Information List
Table Roche Diagnostics? Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Diagnostics? Biosimilars Global Market Share (2011-2016)
Table Merck KGaA Basic Information List
Table Merck KGaA Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck KGaA Biosimilars Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biosimilars
Table Distributors/Traders List
Figure Global Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Global Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Global Biosimilars Sales Forecast by Regions (2016-2021)
Table Global Biosimilars Sales Forecast by Type (2016-2021)
Table Global Biosimilars Sales Forecast by Application (2016-2021)
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...